4//SEC Filing
Friedlaender Gary E 4
Accession 0001209191-13-014356
CIK 0001138400other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 7:49 PM ET
Size
37.4 KB
Accession
0001209191-13-014356
Insider Transaction Report
Form 4
Friedlaender Gary E
Director
Transactions
- Disposition to Issuer
Common Stock
2013-03-01−14,894→ 0 total(indirect: By Trust) - Disposition to Issuer
Common Stock
2013-03-01−4,258→ 0 total(indirect: As Custodian for Grandson) - Disposition to Issuer
Common Stock
2013-03-01−4,258→ 0 total(indirect: As Custodian for Granddaughter) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−5,831→ 0 totalExercise: $17.09Exp: 2017-06-21→ Common Stock (5,831 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,840→ 0 totalExercise: $11.64Exp: 2018-06-19→ Common Stock (8,840 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−8,538→ 0 totalExercise: $12.66Exp: 2020-06-17→ Common Stock (8,538 underlying) - Exercise/Conversion
Common Stock
2013-03-01$5.80/sh+18,736$108,669→ 62,731 total - Exercise/Conversion
Common Stock
2013-03-01$2.63/sh+20,000$52,600→ 70,754 total - Tax Payment
Common Stock
2013-03-01$9.07/sh−5,797$52,579→ 64,957 total - Disposition to Issuer
Common Stock
2013-03-01−64,957→ 0 total - Disposition to Issuer
Common Stock
2013-03-01−11,762→ 0 total(indirect: By Trust) - Exercise/Conversion
Stock Options (right to buy)
2013-03-01−18,736→ 0 totalExercise: $5.80Exp: 2021-06-14→ Common Stock (18,736 underlying) - Exercise/Conversion
Stock Options (right to buy)
2013-03-01−20,000→ 0 totalExercise: $2.63Exp: 2022-06-11→ Common Stock (20,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2013-03-01−10,653→ 0 totalExercise: $9.95Exp: 2019-06-18→ Common Stock (10,653 underlying) - Tax Payment
Common Stock
2013-03-01$9.07/sh−11,977$108,631→ 50,754 total - Disposition to Issuer
Common Stock
2013-03-01−3,377→ 0 total(indirect: As Custodian for Granddaughter)
Footnotes (8)
- [F1]This transaction represents a withholding of shares to cover the payment of exercise price pursuant to an exercise of non-qualified stock options.
- [F2]Disposed of pursuant to the Agreement and Plan of Merger ("Merger Agreement") dated as of November 19, 2012, by and among the Company, Wright Medical Group, Inc. ("Wright"), Achilles Merger Subsidiary, Inc. and Achilles Acquisition Subsidiary, LLC in exchange for the following merger consideration per share of the Company's common stock: (a) $1.50 in cash, without interest; (b) 0.2482 of a share of Wright's common stock; and (c) one contingent value right ("CVR") issued by Wright.
- [F3]Dr. Friedlaender disclaims beneficial ownership of these shares.
- [F4]Option exercised. Pursuant to the Merger Agreement, this stock option was conditionally vested to 100% subject to exercise upon the merger transaction. The reporting person received merger consideration described in footnote (2) above.
- [F5]Option canceled. Pursuant to the Merger Agreement, the reporting person entered into an agreement with the issuer to terminate stock options with an exercise price greater than $13.00.
- [F6]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,613 shares of Wright common stock at an exercise price of $22.31 per share.
- [F7]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 5,559 shares of Wright common stock at an exercise price of $19.07 per share.
- [F8]Pursuant to the Merger Agreement, the stock options granted by the issuer converted into options to purchase 4,455 shares of Wright common stock at an exercise price of $24.26 per share.
Issuer
BIOMIMETIC THERAPEUTICS, INC.
CIK 0001138400
Entity typeother
Related Parties
1- filerCIK 0001375095
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 7:49 PM ET
- Size
- 37.4 KB